Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCIHirotoshi Watanabe, Nobuhiro Suematsu, Takafumi Yokomatsu et al.|JAMA|2019Cited by 830
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary SyndromeHirotoshi Watanabe, Motoaki Higuchi, Takeshi Morimoto et al.|JAMA Cardiology|2022Cited by 296
Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary InterventionMasahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi et al.|Circulation Cardiovascular Interventions|2019Cited by 135
Late Adverse Events After Implantation of Sirolimus-Eluting Stent and Bare-Metal StentMasahiro Natsuaki, Takeshi Kimura, Takeshi Morimoto et al.|Circulation Cardiovascular Interventions|2014Cited by 77
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trialTakeshi Kimura, Hirotoshi Watanabe, Takenori Domei et al.|Cardiovascular Intervention and Therapeutics|2020Cited by 62